Files
Download Full Text (2.2 MB)
Contents
- Gastric Cancer Studies Focus on Prolonging Survival and Finding Molecular Markers for Targeted Therapies
- Clinical Ethicists Help Patients, Families, and Staff Resolve Difficult Dilemmas
- An Unexpected Finding: Male Breast Cancer Is Rare and Often Overlooked
- House Call: Getting Screened for Oral Cancer
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
2004
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Ajani, Jaffer A.; Yao, James C.; Crane, Christopher; Xie, Keping; Smith, Martin L.; Flamm, Anne L.; Evans, Barbara J.; Davis, Vanessa L.; Giordano, Sharon; Stomach Neoplasms; Helicobacter pylori; Surgical Procedures, Operative; Antineoplastic Agents; Chemoradiotherapy; Fluorouracil; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Drug Resistance, Neoplasm; Radiotherapy; Sp1 Transcription Factor; Vascular Endothelial Growth Factors; Angiogenesis Inducing Agents; Ethics, Clinical; Advance Care Planning; Breast Neoplasms, Male; Genes, BRCA2; Receptors, Estrogen; Tamoxifen; Mouth Neoplasms; Publications; Biopsy; Luminescence.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Matias, Katie Prout and Stuyck, Karen, "OncoLog, Volume 49, Number 04, April 2004" (2004). OncoLog MD Anderson's Report to Physicians (All issues). 128.
https://openworks.mdanderson.org/oncolog/128
Conditions Governing Access
Open
